Clinical Trial Update: Saginil in vs. Placebo for Gynecologic Oncology Patients Affected by Vaginitis [Phase 2, Phase 3]

View source ↗

Summary

An update on a Phase 2/Phase 3 trial evaluating Saginil versus placebo for vaginitis in gynecologic oncology patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Vaginitis

Drugs mentioned

• Saginil

Snippet

Sponsor: Università degli Studi dell'Insubria | Conditions: Vaginitis | Phase 2, Phase 3 | Status: UNKNOWN